Compare Illumina, Inc. (ILMN) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Medtronic PLC — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while Medtronic PLC trades at $82.79 (market cap $106.61B). The key difference: Medtronic PLC is far larger — about 3.8× Illumina, Inc.'s market cap, and Medtronic PLC pays a 3.46% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | MDT | |
|---|---|---|
Market Cap | $27.94B | $106.61B |
Sector | Health | Health |
52-Week High | $194.33 | $105.35 |
52-Week Low | $91.00 | $73.75 |
Enterprise Value | $29.33B | $125.36B |
Dividend Yield | — | 3.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
